Directed evolution of light-activated drugs

Medical Hypotheses

Volumn 53, Issue 6, 1999, Pages 504-506

  Hall, K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIRECTED MOLECULAR EVOLUTION; DRUG TARGETING; LIGHT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0033374551     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0799     Document Type: Article

References (10)

1. Fisher A. M. R., Murphree A. L., Gomer C. J. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 17:1995;2-31.
2. Levy J. G. Photodynamic therapy. TIB Tech. 13:1995;14-18.
3. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumors. J Photochem Photobiol. 39:1997;1-18.
4. Joyce G. F. Directed molecular evolution. Sci Am. 267:1992;89-97.
5. Kauffman S. A. Applied molecular evolution. J Theor Biol. 157:1992;1-7.
6. Flam F. Co-opting a blind watchmaker. Science. 265:1994;1032-1033.
7. Breaker R. R., Joyce G. F. Inventing and improving ribozyme function: rational design versus iterative selection methods. TIB Tech. 12:1994;268-275.
8. Brock L. C., Griffin L. C., Latham J. A. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 355:1992;564-566.
9. Brenner S., Lerner R. A. Encoded combinatorial chemistry. Proc Natl Acad Sci USA. 89:1992;5381-5383.
10. Roberts R. W., Szostak J. W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci USA. 94:1997;12297-12302.